Drug news
Ferring licenses elobixibat from Albireo for Chronic Constipation and IBS.
Ferring has licensed from Albireo the world rights to elobixibat, excluding those territories held by Ajimoto. Elobixibat is a first-in-class investigational drug in development for Chronic Constipation and Irritable Bowel Syndrome with Constipation.